AMERICAN SOCIETY OF PHARMACOGNOSY FOUNDATION (EIN 251581459) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Principal Officer

KIRK MANFREDI PH D

Phone

6164501762

Tax Period

2024-01-01 to 2024-12-31

AMERICAN SOCIETY OF PHARMACOGNOSY FOUNDATION is a small nonprofit that reported $243K in total revenue in fiscal year 2024. Revenue surged 222% from the prior year, signaling strong growth momentum. The organization ran a surplus of $157K, a strong 64% operating margin.

Mission

AS EMBODIED IN ITS BY-LAWS, THE AMERICAN SOCIETY OF PHARMACOGNOSY FOUND- ATION IS ORGANIZED TO PROMOTE, SUPPORT AND FURTHER THE INTERESTS AND PURPOSES OF THE AMERICAN SOCIETY OF PHARMACOGNOSY IN THE AREAS OF CHARITY, SCIENCE & EDUCATION, AS DEFINED AND LIMITED BY SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $45,974

Program Service Revenue $0

Investment Income $190,446

Other Revenue $6,823

TOTAL REVENUE $243,243

Expense Breakdown

Grants Paid $78,750

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $78,750

Other Expenses $7,697

TOTAL EXPENSES $86,447

Year-over-Year Comparison

	2024	2023	Change
Revenue	$243,243	$75,543	+2.2%
Expenses	$86,447	$116,243	-0.3%
Net Income	$156,796	$-40,700	-4.9%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EMILY BRITTON	MEMBER AT LA	N/A	Director	$0	$0	$0
JOHN CARDELLINA	CHAIRPERSON	N/A	Director	$0	$0	$0
C BENJAMIN NAMAN	MEMBER AT LA	N/A	Director	$0	$0	$0
CEDRIC PEARCE PHD	MEMBER AT LA	N/A	Director	$0	$0	$0
CINDY K ANGERHOFER PHD	MEMBER AT LA	N/A	Director	$0	$0	$0
STEVE SWENSON	MEMBER AT LA	N/A	Director	$0	$0	$0
MELANY PUGLISI-WEENING PH D	SECRETARY	N/A	Officer	$0	$0	$0
KIRK MANFREDI PH D	TREASURER	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$243,243	$86,447	$2,719,608	$156,796
2023	$75,543	$116,243	$2,563,412	$-40,700
2022	$357,533	$123,326	$2,624,512	$234,207
2021	$181,236	$102,902	$2,370,805	$78,334
2020	$49,078	$53,361	$2,292,471	$-4,283
2019	$193,609	$85,402	$2,323,754	$108,207
2018	$529,230	$105,094	$2,195,047	$424,136

AMERICAN SOCIETY OF PHARMACOGNOSY FOUNDATION